Obinutuzumab schließt eine Lücke in der CLL-Therapie
Crossref DOI link: https://doi.org/10.1007/s11654-014-0558-2
Published Online: 2014-12-02
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
pm,
Text and Data Mining valid from 2014-12-01